A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 million price tag.
|01/13/2019||Posted by BusinessMediaguide.Com under General World News||
- A one-time treatment for a devastating rare disease could be paid for with an installment plan as soon as this summer in Massachusetts.
- Novartis’s AveXis unit is involved in the discussions. Its gene therapy could cost up to $5 million per treatment.
- Organizers hope the plan will ensure patients can access a potentially life-changing treatment.
- Business Insider is the first to report on the discussions and the interest from AveXis.
In recent years, no treatments were even available for the rare, devastating disease known as spinal muscular atrophy.
Now, in a matter of months, an experimental one-time therapy designed to address read more >>>